Surprisingly, a previous study revealed that pharmacologic inhibition of MEK promotes growth and proliferation of patient T‐ALL cells when co‐cultured with stromal cells, while maintaining LIC activity101. Here, MAP2K7 is linked to acute lymphoblastic leukemia.